Research and Development

UK healthcare comms consultancy firm Triducive has appointed a new senior account manager in Ian Walker. Walker is a project …

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …

Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely …

Three new research programmes that aim to deliver a step-change in the understanding of disease by using human volunteers in …

Medical device firm Owen Mumford is strengthening its marketing team with three new appointments.   Two of the positions are …

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

The Anglo-American John O’Keefe and Norwegian couple May-Britt and Edvard Moser have all won the 2014 Nobel Prize for medicine …

NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This …

Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. McLellan is to be …

The government has injected £12.5 million into the research institutions of Norwich Research Park to fund its doctoral training programme. …

The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …

Following a $40 million investment from The Wellcome Trust and the Bill & Melinda Gates Foundation, biopharma UK firm Kymab …

Healthcare tech services firm M3 Europe has appointed a business director for its European division in Paul Townley-Jones.

The first TB medication to be approved in four decades and the first ever vaccine to treat invasive meningococcal disease …